|
| Press Releases |
|
 |
|
| Tuesday, October 3, 2023 |
|
|
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 |
| more info >> |
|
| Monday, August 28, 2023 |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies |
| HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies more info >> |
|
| Monday, July 24, 2023 |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
| Monday, April 17, 2023 |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| more info >> |
|
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies |
| HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TruMerit與Credivera為全球醫療保健專業人員頒發首批可驗證數位憑證
May 8, 2026 23:00 HKT/SGT
|
|
|
TruMerit与Credivera为全球医疗保健专业人员颁发首批可验证数字证书
May 8, 2026 23:00 HKT/SGT
|
|
|
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
May 8, 2026 23:00 HKT/SGT
|
|
|
エーザイとバイオジェン・インク、抗 Aβ抗体レカネマブの皮下注射製剤「LEQEMBI(R) IQLIK(TM)」の早期アルツハイマー病に対する初期療法に関する米国 FDA による優先審査の状況について
May 8, 2026 17:00: JST
|
|
|
阿斯利康與OMP在2026年Gartner供應鏈研討會暨博覽會展示「以變化速度進行規劃」
May 8, 2026 17:00 HKT/SGT
|
|
|
阿斯利康与OMP在2026年Gartner供应链研讨会暨博览会展示“以变化速度进行规划”
May 8, 2026 17:00 HKT/SGT
|
|
|
Sydney and Melbourne kick off ninth edition of PropertyGuru Asia Property Awards in Australia
May 8, 2026 14:40 HKT/SGT
|
|
|
How to Travel More Often Without Increasing Your Budget
May 8, 2026 13:00 HKT/SGT
|
|
|
CNNオリジナルシリーズ「K-Everything」初回エピソード ダニエル・デイ・キムがK-POPの国際舞台における驚異的な躍進に迫る
May 8, 2026 11:50: JST
|
|
|
How to Clear the Strait of Hormuz from the Air: UMag Solutions Launches F1Mag(R) - an Unmanned Solution for Rapid Naval Mine Detection and Anti-Submarine Warfare
May 7, 2026 20:30 HKT/SGT
|
|
|
How to Clear the Strait of Hormuz from the Air: UMag Solutions Launches F1Mag(R) - an Unmanned Solution for Rapid Naval Mine Detection and Anti-Submarine Warfare
May 7, 2026 20:30 HKT/SGT
|
|
|
How to Clear the Strait of Hormuz from the Air: UMag Solutions Launches F1Mag(R) - an Unmanned Solution for Rapid Naval Mine Detection and Anti-Submarine Warfare
May 7, 2026 20:30 HKT/SGT
|
|
|
AstraZeneca and OMP Demonstrate Planning at the Speed of Change at Gartner Supply Chain Symposium/Xpo(TM) 2026
May 7, 2026 20:00 HKT/SGT
|
|
|
豪華新能源車企賽力斯銷量數據亮眼：今年1-4月纍計超11萬輛 同比增長30%
May 7, 2026 17:43 HKT/SGT
|
|
|
豪华新能源车企赛力斯销量数据亮眼：今年1-4月累计超11万辆 同比增长30%
May 7, 2026 17:38 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
